Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Gas prices keep rising, but major oil companies have not signaled a surge in drilling to curb the pump. Here’s what d...
Imagine income investments that don’t just pay a dividend, they propel total returns. This article highlights three d...
When markets tumble, some dividend stocks stand out as thoughtful buys. This article explains how to spot a truly res...
A Brookings study released this spring estimates ICE enforcement costs the economy about 668,000 jobs, unraveling the...
A historic SpaceX IPO would signal a new chapter for private space ventures. Mueller, SpaceX’s first employee, now le...
When a company's CFO sells a chunk of shares, investors want to know what it means. This guide explains the implicati...
A surprise leadership shift at JPMorgan ends years of grooming female executives for the corner office. Marianne Lake...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
Stocks faced a rough start to the week as tariff headlines rattled markets and Nvidia prepares its earnings reveal. L...
Two century-old dividend histories anchor a growing conversation about reliable income in today’s volatile markets. Y...
Two tech powerhouses sit at the AI crossroads. This article breaks down the nvidia stock micron stock dynamic, what h...